NCT06788509 2026-04-13A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringJanssen Research & Development, LLCPhase 1 Enrolling by invitation120 enrolled
NCT06709040 2026-04-06A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical ParametersNovo Nordisk A/SEnrolling by invitation500 enrolled
NCT07218003 2026-03-23A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Rondo TherapeuticsPhase 1 Enrolling by invitation149 enrolled
NCT07226180 2026-03-18Development and Application of Patient-Derived Models of CancerCertis Oncology Solutions, IncEnrolling by invitation40 enrolled
NCT06701201 2026-02-10A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell ProductVerismo TherapeuticsEnrolling by invitation60 enrolled
NCT05645536 2026-01-12Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyTolmar Inc.Phase 3 Enrolling by invitation250 enrolled
NCT06674538 2025-09-22Clinical Trial to Treat Stage IV Cancer PatientsMoonshot AntibodiesPhase 1 Enrolling by invitation12 enrolled
NCT07046832 2025-07-02Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue BiopsyMediView XR, Inc.Phase NA Enrolling by invitation104 enrolled
NCT05889806 2023-06-05AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)Audubon BioscienceEnrolling by invitation10,000 enrolled